Explorando a realidade dos exossomos na Dermatologia
Published: Jan. 1, 2025
Exosome Revolution or Marketing Mirage? AI-Based Multi-domain Evaluation of Claims, Scientific Evidence, Transparency, Public Sentiment, and Media Narratives
Eqram Rahman,
No information about this author
Karim Sayed,
No information about this author
Parinitha Rao
No information about this author
et al.
Aesthetic Plastic Surgery,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 7, 2025
Language: Английский
Regenerative topical skincare: stem cells and exosomes
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Oct. 15, 2024
Regenerative
medicine
and
its
offshoot,
regenerative
aesthetics,
have
been
hot
topics
over
the
past
15
years.
Studies
with
heterochronic
parabiosis
others
pointed
to
a
circulating
factor
that
could
rejuvenate
aging
tissues.
Stem
cells
are
known
powers,
but
they
difficult
extract,
grow
in
culture
or
maintain.
Exosomes
(EVs),
extracellular
vesicles
from
30
150
nm,
discovered
be
primary
form
of
communication
between
Using
stem
cell
supernatants
generate
desirable
EVs
has
become
heralded
treatment
for
aesthetic
treatments.
Preclinical
studies
show
many
benefits
including
improving
function
fibroblasts
healing
wounds
more
rapidly.
Clinical
aesthetics
very
few.
Thus,
excitement
generated
by
should
tempered
realism
about
lack
available
products
as
well
scientific
proof.
Language: Английский
From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications
Cells,
Journal Year:
2024,
Volume and Issue:
13(24), P. 2052 - 2052
Published: Dec. 12, 2024
Cellular
rejuvenation
therapies
represent
a
transformative
frontier
in
addressing
age-related
decline
and
extending
human
health
span.
By
targeting
fundamental
hallmarks
of
aging—such
as
genomic
instability,
epigenetic
alterations,
mitochondrial
dysfunction,
cellular
senescence—these
aim
to
restore
youthful
functionality
cells
tissues,
offering
new
hope
for
treating
degenerative
diseases.
Recent
advancements
have
showcased
range
strategies,
including
reprogramming,
senolytic
interventions,
restoration,
stem
cell-based
approaches,
gene-editing
technologies
like
CRISPR.
Each
modality
has
demonstrated
substantial
potential
preclinical
models
is
now
being
cautiously
explored
early-stage
clinical
trials.
However,
translating
these
from
the
laboratory
practice
presents
unique
challenges:
safety
concerns,
delivery
precision,
complex
regulatory
requirements,
ethical
considerations,
high
costs
impede
widespread
adoption.
This
review
examines
current
landscape
rejuvenation,
highlighting
key
advancements,
risks,
strategies
needed
overcome
hurdles.
Language: Английский